Treat the bone, not the fear: antiosteoporosis medications and fracture healing
Author:
Open Access
- 2 June 2026
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (5) , 100834
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysisThe Lancet Healthy Longevity, 2026
- Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative reviewOsteoporosis International, 2024
- The significance of recent fracture location for imminent risk of hip and vertebral fractures—a nationwide cohort study on older adults in SwedenOsteoporosis International, 2024
- Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment RatesThe Journal of Clinical Endocrinology & Metabolism, 2022
- Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTSThe Journal of Clinical Endocrinology & Metabolism, 2021
- The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS StudyJournal of Bone and Mineral Research, 2020
- OsteoporosisThe Lancet, 2019
- Association between timing of zoledronic acid infusion and hip fracture healingOsteoporosis International, 2010
- Optimal Timing of a Single Dose of Zoledronic Acid to Increase Strength in Rat Fracture RepairJournal of Bone and Mineral Research, 2007